https://regulatorynews.com/cms-tavr-single-operator-coverage-change Regulatory News en 2026-09-29T11:07:53-04:00 CMS Ends TAVR's Mandatory Two-Operator Rule https://regulatorynews.com/si-bone-ifuse-granite-onyx-clearance Regulatory News en 2026-09-29T11:07:53-04:00 FDA Clears SI-BONE Implant for Fusion Screw Loosening https://regulatorynews.com/capsovision-ai-highlights-fda-clearance Regulatory News en 2026-09-29T09:35:47-04:00 CapsoVision Clears FDA for AI-Assisted Capsule Endoscopy https://regulatorynews.com/kasvu-therapeutics-ktx0141-series-a Regulatory News en 2026-09-29T09:35:47-04:00 Kasvu Raises €30M Series A for TrkB Depression Drug https://regulatorynews.com/quoin-pharmaceuticals-qrx003-fast-track-pss Regulatory News en 2026-09-29T09:35:47-04:00 Quoin Wins First-Ever Fast Track for Peeling Skin Syndrome https://regulatorynews.com/emcitate-mct8-deficiency-approval Regulatory News en 2026-09-29T05:53:41-04:00 FDA Approves First-Ever Treatment for MCT8 Deficiency https://regulatorynews.com/route92-freeclimb46-fda-clearance Regulatory News en 2026-09-29T05:53:41-04:00 Route 92 Medical Clears FDA for FreeClimb 46 https://regulatorynews.com/tga-biov8-peptide-advertising-prosecution Regulatory News en 2026-09-29T05:53:41-04:00 TGA Sues BioV8 Directors Over Illegal Peptide Ads https://regulatorynews.com/fayuvi-sanfilippo-syndrome-gene-therapy Regulatory News en 2026-09-28T10:44:27-04:00 FAYUVI's Label Limits It to Early-Stage Sanfilippo https://regulatorynews.com/gazyva-rituximab-nephrotic-syndrome Regulatory News en 2026-09-28T10:44:27-04:00 FDA Approves First Drug for Relapsing Nephrotic Syndrome https://regulatorynews.com/adarx-pharmaceuticals-nasdaq-ipo Regulatory News en 2026-09-28T09:31:41-04:00 ADARx Prices $446M IPO to Fund Onvuzosiran https://regulatorynews.com/leo-pharma-anzupgo-adolescent-chmp-opinion Regulatory News en 2026-09-28T09:31:41-04:00 LEO Pharma Wins CHMP Nod to Treat Teen Eczema https://regulatorynews.com/xenix-medical-riva-anchor-fda-clearance Regulatory News en 2026-09-28T09:31:41-04:00 Xenix Medical Clears FDA for Riva Anchor SI Implant https://regulatorynews.com/spectra-saline-flush-sterility-recall Regulatory News en 2026-09-28T06:06:32-04:00 FDA Cites Sterility Risk in Spectra Saline Flush Recall https://regulatorynews.com/fda-mdic-regulatory-science-meeting Regulatory News en 2026-09-28T06:01:48-04:00 FDA and MDIC Meet to Set Device Science Priorities https://regulatorynews.com/gazyva-idiopathic-nephrotic-syndrome-approval Regulatory News en 2026-09-28T06:01:48-04:00 FDA Approves Gazyva for Childhood Nephrotic Syndrome https://regulatorynews.com/belzutifan-lenvatinib-post-io-kidney-cancer Regulatory News en 2026-09-28T00:49:31-04:00 FDA Approves Belzutifan-Lenvatinib Combo for Kidney Cancer https://regulatorynews.com/imlunestrant-abemaciclib-esr1-mutation-testing Regulatory News en 2026-09-28T00:49:31-04:00 FDA Approves Oral SERD Combo for ESR1+ Breast Cancer https://regulatorynews.com/onswik-weekly-insulin-fda-approval Regulatory News en 2026-09-27T18:16:57-04:00 FDA Approves Onswik, Lilly's Once-Weekly Basal Insulin https://regulatorynews.com/vitruvias-thyroid-tablets-class-i-recall Regulatory News en 2026-09-27T18:05:50-04:00 FDA Recalls Vitruvias Thyroid Tablets Over Superpotency https://regulatorynews.com/winrevair-early-pah-treatment-window Regulatory News en 2026-09-27T18:05:50-04:00 FDA Label Now Backs Early Winrevair Use in PAH